Wanjia Group Holdings Ltd

HKSE • Healthcare • Medical Distribution • Quote as of 10/30/2026

Company Profile

IndustryMedical Distribution

SectorHealthcare

ExchangeHKSE

Market Capitalization113.99 mln

Float1,129 mln

Earnings Date11/25/2026

Piotroski F-Score

3 / 9

Below average

Beneish M-Score

-1.73

Likely manipulated

Relative Strength

90 / 100

Top performer

Debt / Equity

0.25

Very low leverage

Pre-Tax Margin

-5%

Marginally loss-making

ROE

-13.59

Negative

Business Description

Wanjia Group Holdings Limited is a Hong Kong-based company that distributes pharmaceutical products across mainland China and Hong Kong, supplying hospitals, clinics, pharmacies, and other healthcare providers. The company also provides hemodialysis treatment and related consultancy services. Founded in 2004, it operates from its headquarters in Kowloon, Hong Kong.

Key Fundamentals

EPS-0.01

ROE-13.59

RPS0.23

ROIC-10.60

ROA-8.51

Interest Cover-10.24

EBITDA, mln-1.28

EV / EBITDA-75.62

EV / EBIT-12.29

Revenue, mln165

EV / Revenue0.58

Quote Details

Last 0.109

Change 0.008 (7.92%)

Open 0.109

Volume 280,000

Turnover 30,520

Average Volume 1,611,408

Financial Ratios

Pre-Tax Profit Margin-5

Leverage Ratio1.58

Current Ratio2.23

Price / Book0.63

Price / Tangible Book0.86

Debt / Equity0.25

Price / Sales0.36

Financial Strength

Altman Z-Score-6.91

Piotroski F-Score 3 / 9

Beneish M-Score-1.73

Price to Intrinsic Value0.95

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	7.92%	92 / 100
1 Month	-18.05%	21 / 100
2 Months	-41.08%	8 / 100
6 Months	-12.8%	57 / 100
1 Year	53.52%	88 / 100